Business Standard

Pfizer enters talks to buy Seagen for over $30 billion, says report

Deal will help the firm add to its line-up of cancer treatments

Pfizer
Premium

Agencies
Pfizer is in talks to acquire biotech Seagen according to people familiar with the matter, the latest potential deal for a big drug company aimed at adding a promising class of targeted cancer therapies, The Wall Street Journal reported.

The talks are at an early stage and there is no guarantee there will be a deal, the people said. A number of hurdles would need to be overcome, including the potential for a stringent antitrust review of any proposal.  If there is a deal, it would be big: Seagen has a market value of some $30 billion and would be expected

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 27 2023 | 10:47 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com